Skip to main content

HUMENIC to Develop its Digital Treatment Device EYAS as a Global Brand

Developed Korea's only computerized cognitive rehabilitation system EYAS in April 2019. Contributes to maximizing the rehabilitation training effect for the cognitively impaired and the group of high risk of reduced cognition.

LOS ANGELES, CA, December 28, 2020 /24-7PressRelease/ -- The computerized cognitive rehabilitation system EYe-Ear-Attention System (EYAS) developed by the human care solution specialist Humenic (CEO Choun Seung-ho) is raising interest in the global market. Recently, EYAS was upgraded to EYAS 2.0 with the Active Care Relationship Service (ACRS) that enables non-face-to-face facial recognition login. With this, Humenic is continuing its reputation as the global top company in the field of cognitive enhancement system.

Founded in 2005, Humenic was established as a research institute company through technology transfer from the parent company IntheTech and Kyungpook National University. The company has been focusing on the IT-based attention ability enhancing contents for the prevention of attention reduction and the recovery and enhancement of attention, and u-Healthcare system for producing it. In April 2019, it has officially launched its visual tracking-linked cognition rehabilitation training system EYAS. Referring to EYAS as a digital treatment equipment, Humenic CEO Choun Seung-ho introduced it by saying, "It is developed so that the automated system using a camera can recognize patients and the therapist can provide care to the patients easily. It is used to prevent dementia and provide cognition rehabilitation training to children suffering from developmental disabilities."

EYAS, the only visually linked cognitive rehabilitation solution in Korea, consists of product lineups such as EYAS PREMIUM, EYAS MULTI, EYAS STANDARD, EYAS 1.0, and EYAS MMSE-K KIT. Among them, EYAS PREMIUM is the only chair-combined premium solution in Korea that considers various experiences of users for computerized cognitive rehabilitation. With the electric chair adjustment and 360° monitor screen, it is optimized for patients with physical disabilities. Also, by using EYAS MULTI, which provides wired/wireless networks and allows free movements and deployment, is designed to allow managers to perform cognitive rehabilitation training for a large number of people by utilizing remote functions.

With the world's first EYE-Link System with technology that connects the patient's vision and system, Auto Ready System with active AI-based trainee facial recognition technology, and Positioning System with the dedicated monitor arm which considers the training positions of the trainees with difficulties in movements by using wheelchairs, EYAS is providing an eight-stage system. With this, Humenic is helping to activate brain function through the cognitive rehabilitation contents program that consists of a variety of contents, from contents that strengthen concentration ability to contents that increase memory and contents that increase calculation and attention ability.

Also, as the importance of non-face-to-face due to COVID-19, Humenic had the need to prepare for it, so it released EYAS 2.0, which enables facial recognition login by automatically recognizing the perspective of the rehabilitation trainees. EYAS 2.0, the next-gen cognitive rehabilitation solution for visual tracking, is equipped with Active Care Relationship Service (ACRS), allowing non-face-to-face facial recognition login.

Humenic has been increasing its brand value in the global market by participating in major overseas exhibitions such as the CES in the US and Medica in Germany every year, and it has successfully signed MOU with major sales connection in the overseas to pioneer overseas market. Humenic's technology has been proven through exports to the UK and Vietnam, and in 2021, it will establish a subsidiary in the UK to go closer to the UK and European markets. With this, the company is on the way to receive the second-level certification on its EYAS medical devices to expand its market in the overseas. They will soon be CE certified and FDA approved.

Founded in 2005, Humenic was established as a research institute company through technology transfer from the parent company IntheTech and Kyungpook National University. The company has been focusing on the IT-based attention ability enhancing contents for the prevention of attention reduction and the recovery and enhancement of attention, and u-Healthcare system for producing it. In April 2019, it has officially launched its visual tracking-linked cognition rehabilitation training system EYAS. Referring to EYAS as a digital treatment equipment, Humenic CEO Choun Seung-ho introduced it by saying, "It is developed so that the automated system using a camera can recognize patients and the therapist can provide care to the patients easily. It is used to prevent dementia and provide cognition rehabilitation training to children suffering from developmental disabilities."

---
Press release service and press release distribution provided by http://www.24-7pressrelease.com
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.